The Society wishes it understood that at present there is no vaccine, serum or inoculation which will secure anyone against influenza. It is desirable that everyone should avoid hysteria and consider only the reports which are officially given out by the Health Department, since of late various methods of prophylaxis and treatment have found their way into the daily newspapers, and these may prove harmful rather than do good. Almost simultaneously the daily papers published the report of Surgeon-General Blue, of the United States Bureau of Public Health, which expressed practically the same opinion. It was not the intention of either of these articles to criticise the practice of vaccination, but merely to warn the public against profiteering and fraudulent guarantees. They had the unexpected effect, however, of causing people to completely lose faith in prophylactic vaccines, and in many instances to become actually antagonistic to them. It was during this period that the preparation of vaccines from pure influenza strains was undertaken, under supervision of the County Society and for distribution through the Department of Public Health. Two days after the first supply of this vaccine was ready the Red Cross authorities telephoned that there was no further call for vaccine. The man in charge of the distribution stated concretely that “the bottom had dropped out of the vaccine business.” A few days later the Department of Health issued an order to stop the preparation of the vaccine. Many pharmacies, having small supplies of vaccines, realized the great call for it and the difficulty of obtaining a new supply, and were also guilty of commercialism. Certain of the large biological product companies were no exception. One house issued a hand-bill, printed in red on a yellow background, which stated: “Epidemic influenza is due to the influenza bacillus. The present epidemic of influenza has a tendency to develop pneumonia. The use of our influenza bacillus vaccine No. —— will abort the influenza and avoid pneumonia and other sequelæ. When pneumonia has developed, it can be reduced to less than one-third the mortality and duration usual with other methods of treatment,” etc. Practically all of the above statements are still unproven, and probably will never be shown to be true. Such a bulletin undoubtedly lays this firm of vaccine manufacturers open to prosecution under the law protecting against false and fraudulent advertising. Several fairly well-authenticated incidents occurred in which the representatives of vaccine houses offered factory managers and others share and share alike in the profits, if the brand of vaccine made by them was used. It is on such happenings as the above that the writer advocates legal measures, allowing Boards of Health to control the advertising of remedies and distribution of biological products during epidemics.